Last Updated: June 24, 2026

OXYMORPHONE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Oxymorphone, and when can generic versions of Oxymorphone launch?

Oxymorphone is a drug marketed by Actavis Elizabeth, Hikma, Impax Labs, Par Pharm, Specgx Llc, Sun Pharm Inds Ltd, Ascent Pharms Inc, Aurolife Pharma Llc, Avanthi Inc, Epic Pharma Llc, and Teva. and is included in thirteen NDAs.

The generic ingredient in OXYMORPHONE is oxymorphone hydrochloride. There are nine drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the oxymorphone hydrochloride profile page.

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for OXYMORPHONE?
  • What are the global sales for OXYMORPHONE?
  • What is Average Wholesale Price for OXYMORPHONE?
Summary for OXYMORPHONE
US Patents:0
Applicants:11
NDAs:13
Drug Prices: Drug price information for OXYMORPHONE
DailyMed Link:OXYMORPHONE at DailyMed

US Patents and Regulatory Information for OXYMORPHONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd OXYMORPHONE HYDROCHLORIDE oxymorphone hydrochloride TABLET, EXTENDED RELEASE;ORAL 203506-006 Apr 24, 2015 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Specgx Llc OXYMORPHONE HYDROCHLORIDE oxymorphone hydrochloride TABLET, EXTENDED RELEASE;ORAL 202946-004 Jun 27, 2014 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Epic Pharma Llc OXYMORPHONE HYDROCHLORIDE oxymorphone hydrochloride TABLET;ORAL 201187-001 Dec 15, 2014 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Aurolife Pharma Llc OXYMORPHONE HYDROCHLORIDE oxymorphone hydrochloride TABLET;ORAL 204459-001 Apr 26, 2016 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Epic Pharma Llc OXYMORPHONE HYDROCHLORIDE oxymorphone hydrochloride TABLET;ORAL 201187-002 Dec 15, 2014 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
DrugChatter Q&A for OXYMORPHONE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.